# ğŸ” FORENSIC COMPLETION AUDIT: PHASES 4-9
**Date:** January 26, 2026  
**Auditor:** AI Development Agent  
**Scope:** v2.0 Blueprint Phases 4-9  
**Status:** âš ï¸ **INCOMPLETE - GAPS IDENTIFIED**

---

## ğŸ“‹ AUDIT METHODOLOGY

**Compliance Criteria:**
1. âœ… **Code Exists** - Module/function present and compiles
2. âœ… **Tests Pass** - Unit, integration, system tests passing
3. âœ… **Docs Updated** - Implementation reports and schemas documented
4. âœ… **No Scaffolds** - No TODO comments or placeholder implementations
5. âœ… **Constitutional** - L51/L34/ALCOA+ compliance

**Audit Process:**
- Scan repository for required modules
- Check function signatures against blueprint
- Verify test coverage
- Validate documentation
- Identify gaps and generate remediation code

---

## ğŸ”´ PHASE 4: DOSE OPTIMIZATION V2

### **Blueprint Requirements:**

**Module:** `PX_Engine/operations/DoseOptimizer_v2.py`

**Required Functions:**
1. `optimize_dose(smiles, admet, protocol_template, target_pk_range, target_pd_range, dose_bounds, interval_options, variability, search_strategy)`
2. `evaluate_regimen(dose_mg, interval_h, admet, pd_params, variability)`
3. `scoring_function(pk_summary, pd_summary, target_pk_range, target_pd_range)`

**Search Strategies:**
- Coarse-to-fine grid search
- Binary search (monotonic metrics)
- Multi-arm optimization

**Integration Points:**
- TrialEngine (mini-trials)
- PK/PD engine
- IIV engine
- Evidence_Package v3

**Tests Required:**
- Unit: scoring, binary search, coarse grid
- Integration: optimizer picks correct dose in known monotonic scenario
- System: orchestrator can call optimizer

---

### **AUDIT FINDINGS:**

```
â•”â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•—
â•‘                   PHASE 4 STATUS                             â•‘
â• â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•£
â•‘ Module DoseOptimizer_v2.py:        âŒ MISSING                â•‘
â•‘ Module DoseOptimizer.py (v1):      ğŸŸ¡ PARTIAL (grid only)    â•‘
â•‘                                                              â•‘
â•‘ Function optimize_dose():          âŒ MISSING                â•‘
â•‘ Function evaluate_regimen():       âŒ MISSING                â•‘
â•‘ Function scoring_function():       âŒ MISSING                â•‘
â•‘                                                              â•‘
â•‘ Search Strategy: Coarse-to-fine:   âŒ MISSING                â•‘
â•‘ Search Strategy: Binary search:    âŒ MISSING                â•‘
â•‘ Search Strategy: Multi-arm:        âŒ MISSING                â•‘
â•‘                                                              â•‘
â•‘ Unit Tests:                         âŒ MISSING                â•‘
â•‘ Integration Tests:                  âŒ MISSING                â•‘
â•‘ System Tests:                       âŒ MISSING                â•‘
â•‘                                                              â•‘
â•‘ Documentation:                      âŒ MISSING                â•‘
â•šâ•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
```

### **EXISTING CODE (PARTIAL):**

**File:** `PX_Engine/operations/DoseOptimizer.py`  
**Status:** ğŸŸ¡ **V1 SCAFFOLD - NOT BLUEPRINT COMPLIANT**

**What Exists:**
- `grid_search_dose()` - Simple AUC target optimization
- No PD support
- No IIV support
- No interval optimization
- No coarse-to-fine
- No binary search

**What's Missing:**
- All v2 features from blueprint
- Multi-dimensional optimization
- Target ranges (not single values)
- PD optimization
- Advanced search strategies

### **REMEDIATION REQUIRED:**

**Priority:** ğŸ”´ **HIGH - PHASE 4 NOT IMPLEMENTED**

**Actions Needed:**
1. Create `DoseOptimizer_v2.py` with blueprint-compliant API
2. Implement `optimize_dose()` with:
   - Target range support (not single value)
   - PK and PD optimization
   - IIV integration
   - Coarse-to-fine search
   - Binary search for monotonic metrics
3. Implement `evaluate_regimen()` - mini-trial wrapper
4. Implement `scoring_function()` - range-based scoring
5. Create `test_dose_optimizer_v2.py` - unit tests (minimum 10)
6. Create `test_dose_optimizer_v2_integration.py` - integration tests (minimum 5)
7. Update system tests to include dose optimization
8. Create `DOSE_OPTIMIZATION_V2_IMPLEMENTATION_COMPLETE.md`

**Estimated Effort:** 2-3 sessions

---

## ğŸ”´ PHASE 5: MANUFACTURABILITY MODELING

### **Blueprint Requirements:**

**Module:** `PX_Engine/operations/Manufacturability.py`

**Required Functions:**
1. `evaluate_manufacturability(smiles, admet)`
2. `calculate_synthetic_accessibility(smiles)`
3. `assess_formulation_feasibility(admet)`
4. `identify_risk_flags(smiles)`
5. `estimate_step_count(smiles)`

**Output Schema:**
```python
{
    "synthetic_accessibility": float,
    "estimated_step_count": int,
    "risk_flags": [...],
    "formulation_risk": "LOW/MEDIUM/HIGH",
    "notes": "Constitutional disclaimers"
}
```

**Integration Points:**
- Evidence_Package v3
- SMILES analysis
- ADMET data

**Tests Required:**
- Unit: SAS monotonicity, risk flag detection
- Integration: dossier includes manufacturability
- System: orchestrator runs with manufacturability enabled

---

### **AUDIT FINDINGS:**

```
â•”â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•—
â•‘                   PHASE 5 STATUS                             â•‘
â• â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•£
â•‘ Module Manufacturability.py:       âŒ MISSING                â•‘
â•‘                                                              â•‘
â•‘ Function evaluate_manufacturability(): âŒ MISSING            â•‘
â•‘ Function calculate_synthetic_accessibility(): âŒ MISSING     â•‘
â•‘ Function assess_formulation_feasibility(): âŒ MISSING        â•‘
â•‘ Function identify_risk_flags(): âŒ MISSING                   â•‘
â•‘ Function estimate_step_count(): âŒ MISSING                   â•‘
â•‘                                                              â•‘
â•‘ Output Schema:                      âŒ MISSING                â•‘
â•‘                                                              â•‘
â•‘ Unit Tests:                         âŒ MISSING                â•‘
â•‘ Integration Tests:                  âŒ MISSING                â•‘
â•‘ System Tests:                       âŒ MISSING                â•‘
â•‘                                                              â•‘
â•‘ Documentation:                      âŒ MISSING                â•‘
â•šâ•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
```

### **EXISTING CODE:**

**Status:** âŒ **NONE - PHASE 5 NOT STARTED**

### **REMEDIATION REQUIRED:**

**Priority:** ğŸŸ¡ **MEDIUM - DEPENDS ON PHASE 4**

**Actions Needed:**
1. Create `Manufacturability.py` with blueprint-compliant API
2. Implement `evaluate_manufacturability()` - main entry point
3. Implement `calculate_synthetic_accessibility()` - SAS scoring
4. Implement `assess_formulation_feasibility()` - ADMET-based
5. Implement `identify_risk_flags()` - SMARTS pattern matching
6. Implement `estimate_step_count()` - heuristic estimation
7. Create `test_manufacturability.py` - unit tests (minimum 8)
8. Create `test_manufacturability_integration.py` - integration tests (minimum 4)
9. Update system tests
10. Create `MANUFACTURABILITY_IMPLEMENTATION_COMPLETE.md`

**Estimated Effort:** 2 sessions

---

## ğŸŸ¡ PHASE 6: EVIDENCE_PACKAGE V3

### **Blueprint Requirements:**

**Schema Version:** 3.0

**New Sections Required:**
1. `iiv` - Population variability summary
2. `adaptive` - Adaptation decisions log
3. `dose_optimization` - Best regimen and search space
4. `manufacturability` - Feasibility assessment

**Schema Structure:**
```python
{
    "version": "3.0",
    "molecule": {...},
    "admet": {...},
    "pk": {...},
    "pd": {...},
    "iiv": {...},           # NEW
    "adaptive": {...},      # NEW
    "dose_optimization": {...},  # NEW
    "manufacturability": {...},  # NEW
    "provenance": {...},
    "constitutional": {...}
}
```

**Integration Points:**
- TrialEngine (IIV + Adaptive)
- DoseOptimizer_v2
- Manufacturability
- All v2.0 features

**Tests Required:**
- JSON schema validation
- Backward compatibility (v2.1 â†’ v3.0)
- Full orchestrator run

---

### **AUDIT FINDINGS:**

```
â•”â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•—
â•‘                   PHASE 6 STATUS                             â•‘
â• â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•£
â•‘ Module Evidence_Package.py:        ğŸŸ¡ PARTIAL (v2.1)         â•‘
â•‘                                                              â•‘
â•‘ Schema Version:                     ğŸŸ¡ v2.1 (needs v3.0)     â•‘
â•‘ Function wrap_trial_simulation():   ğŸŸ¡ PARTIAL (no IIV/Adapt)â•‘
â•‘                                                              â•‘
â•‘ Section: iiv:                       âŒ MISSING                â•‘
â•‘ Section: adaptive:                  âŒ MISSING                â•‘
â•‘ Section: dose_optimization:         âŒ MISSING                â•‘
â•‘ Section: manufacturability:         âŒ MISSING                â•‘
â•‘                                                              â•‘
â•‘ JSON Schema Validation:             âŒ MISSING                â•‘
â•‘ Backward Compatibility Tests:       âŒ MISSING                â•‘
â•‘                                                              â•‘
â•‘ Documentation:                      ğŸŸ¡ PARTIAL (needs v3 spec)â•‘
â•šâ•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
```

### **EXISTING CODE (PARTIAL):**

**File:** `PX_System/foundation/Evidence_Package.py`  
**Status:** ğŸŸ¡ **V2.1 - NEEDS V3.0 UPGRADE**

**What Exists:**
- `wrap_trial_simulation()` - Trial dossier generation
- PK/PD support (v2.1)
- Basic constitutional metadata

**What's Missing:**
- IIV summary section
- Adaptive decisions section
- Dose optimization section
- Manufacturability section
- Schema version 3.0
- JSON schema validation

### **REMEDIATION REQUIRED:**

**Priority:** ğŸŸ¡ **MEDIUM - DEPENDS ON PHASES 4-5**

**Actions Needed:**
1. Upgrade `wrap_trial_simulation()` to v3.0:
   - Add `iiv` section (from trial_result)
   - Add `adaptive` section (from adaptation_log)
   - Add `dose_optimization` section
   - Add `manufacturability` section
2. Update schema version to "3.0"
3. Create JSON schema file for validation
4. Implement `validate_dossier_v3()` function
5. Create `test_evidence_package_v3.py` - schema tests
6. Create `test_evidence_package_v3_integration.py` - backward compat
7. Update documentation to v3.0 spec
8. Create `EVIDENCE_PACKAGE_V3_SPECIFICATION.md`

**Estimated Effort:** 1-2 sessions

---

## ğŸ”´ PHASE 7: SYSTEM OPTIMIZATION

### **Blueprint Requirements:**

**Tasks:**
1. Remove deprecated scaffolds
2. Optimize PK/PD loops
3. Optimize TrialEngine loops
4. Add caching for repeated PK/PD calls
5. Add profiling hooks
6. Add memory-safe batching

---

### **AUDIT FINDINGS:**

```
â•”â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•—
â•‘                   PHASE 7 STATUS                             â•‘
â• â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•£
â•‘ Scaffold Removal:                   âŒ NOT STARTED            â•‘
â•‘ PK/PD Loop Optimization:            âŒ NOT STARTED            â•‘
â•‘ TrialEngine Optimization:           âŒ NOT STARTED            â•‘
â•‘ Caching Implementation:             âŒ NOT STARTED            â•‘
â•‘ Profiling Hooks:                    âŒ NOT STARTED            â•‘
â•‘ Memory-Safe Batching:               âŒ NOT STARTED            â•‘
â•‘                                                              â•‘
â•‘ Performance Benchmarks:             âŒ MISSING                â•‘
â•‘ Optimization Report:                âŒ MISSING                â•‘
â•šâ•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
```

### **EXISTING CODE:**

**Status:** âŒ **NONE - PHASE 7 NOT STARTED**

### **REMEDIATION REQUIRED:**

**Priority:** ğŸŸ¢ **LOW - POLISH PHASE**

**Actions Needed:**
1. Audit code for scaffolds and TODOs
2. Profile PK/PD simulation loops
3. Implement result caching (LRU cache)
4. Add profiling decorators
5. Implement batch processing for large populations
6. Create performance benchmark suite
7. Create `OPTIMIZATION_REPORT.md`

**Estimated Effort:** 1 session

---

## ğŸ”´ PHASE 8: ORCHESTRATOR V2

### **Blueprint Requirements:**

**New Stages:**
- Stage 10: Dose Optimization
- Stage 11: Manufacturability
- Stage 12: Evidence_Package v3

**Integration:**
- Full v2.0 pipeline end-to-end
- SMILES â†’ Dossier with all features

---

### **AUDIT FINDINGS:**

```
â•”â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•—
â•‘                   PHASE 8 STATUS                             â•‘
â• â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•£
â•‘ Orchestrator v2 Module:            âŒ MISSING                â•‘
â•‘                                                              â•‘
â•‘ Stage 10 (Dose Opt):                âŒ MISSING                â•‘
â•‘ Stage 11 (Manufacturability):       âŒ MISSING                â•‘
â•‘ Stage 12 (Evidence v3):             âŒ MISSING                â•‘
â•‘                                                              â•‘
â•‘ Full Pipeline Integration:          âŒ NOT STARTED            â•‘
â•‘ End-to-End Tests:                   âŒ MISSING                â•‘
â•‘                                                              â•‘
â•‘ Documentation:                      âŒ MISSING                â•‘
â•šâ•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
```

### **EXISTING CODE:**

**Status:** âŒ **NONE - PHASE 8 NOT STARTED**

**Note:** No orchestrator v2 found in repository.

### **REMEDIATION REQUIRED:**

**Priority:** ğŸŸ¡ **MEDIUM - DEPENDS ON PHASES 4-6**

**Actions Needed:**
1. Create `PX_Orchestrator_v2.py`
2. Implement Stage 10: Dose Optimization
3. Implement Stage 11: Manufacturability
4. Implement Stage 12: Evidence_Package v3
5. Integrate all v2.0 features
6. Create end-to-end pipeline tests
7. Create `ORCHESTRATOR_V2_IMPLEMENTATION_COMPLETE.md`

**Estimated Effort:** 1 session

---

## ğŸ”´ PHASE 9: FINAL VALIDATION

### **Blueprint Requirements:**

**Certification Criteria:**
- 100% tests passing
- Zero regressions
- All documentation complete
- All stages integrated
- All schemas validated
- All constitutional rules satisfied

---

### **AUDIT FINDINGS:**

```
â•”â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•—
â•‘                   PHASE 9 STATUS                             â•‘
â• â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•£
â•‘ 100% Tests Passing:                 ğŸŸ¡ 97/97 (Phases 1-3 only)â•‘
â•‘ Zero Regressions:                   âœ… YES (current system)   â•‘
â•‘ Documentation Complete:              ğŸŸ¡ PARTIAL (Phases 1-3)  â•‘
â•‘ All Stages Integrated:               âŒ NO (4-6 missing)      â•‘
â•‘ Schema Validation:                   âŒ NO (v3.0 missing)     â•‘
â•‘ Constitutional Compliance:           âœ… YES (L51/L34/ALCOA+)  â•‘
â•‘                                                              â•‘
â•‘ Partner-Ready Certification:         âŒ NOT ACHIEVED          â•‘
â•šâ•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
```

### **EXISTING STATUS:**

**What's Complete:**
- Phases 1-3: âœ… Complete (PK/PD, IIV, Adaptive)
- 97 tests passing (20 Phase 1 + 17 Phase 2 + 14 Phase 3 + 46 system)
- Zero regressions
- Constitutional compliance maintained

**What's Missing:**
- Phases 4-6 implementation
- Phases 7-8 integration
- Final validation suite

### **REMEDIATION REQUIRED:**

**Priority:** ğŸ”´ **CRITICAL - FINAL MILESTONE**

**Actions Needed:**
1. Complete Phases 4-6
2. Complete Phases 7-8
3. Run full validation suite
4. Generate partner-ready certification report
5. Create `PREDATOR_X_V2.0_CERTIFICATION.md`

**Estimated Effort:** 1 session (after Phases 4-8 complete)

---

## ğŸ“Š OVERALL AUDIT SUMMARY

```
â•”â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•—
â•‘           v2.0 BLUEPRINT COMPLETION STATUS                   â•‘
â• â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•£
â•‘ Phase 1 (PK/PD):          âœ… COMPLETE (20 tests)            â•‘
â•‘ Phase 2 (IIV):            âœ… COMPLETE (17 tests)            â•‘
â•‘ Phase 3 (Adaptive):       âœ… COMPLETE (14 tests)            â•‘
â•‘ Phase 4 (Dose Opt v2):    âŒ NOT STARTED                     â•‘
â•‘ Phase 5 (Manufacturability): âŒ NOT STARTED                  â•‘
â•‘ Phase 6 (Evidence v3):    ğŸŸ¡ PARTIAL (needs upgrade)        â•‘
â•‘ Phase 7 (Optimization):   âŒ NOT STARTED                     â•‘
â•‘ Phase 8 (Orchestrator v2): âŒ NOT STARTED                    â•‘
â•‘ Phase 9 (Validation):     ğŸŸ¡ PARTIAL (Phases 1-3 only)      â•‘
â•‘                                                              â•‘
â•‘ Overall Progress:         3/9 phases (33%)                  â•‘
â•‘ Tests Passing:            97/97 (current system)            â•‘
â•‘ Estimated Remaining:      8-12 sessions                     â•‘
â•šâ•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
```

---

## ğŸ¯ PRIORITY REMEDIATION ROADMAP

### **Critical Path (Phases 4-6):**

**1. Phase 4 - Dose Optimization v2** ğŸ”´ **HIGHEST PRIORITY**
- **Effort:** 2-3 sessions
- **Blockers:** None (ready to start)
- **Deliverables:**
  - `DoseOptimizer_v2.py` (400-500 lines)
  - Unit tests (minimum 10)
  - Integration tests (minimum 5)
  - Implementation report

**2. Phase 5 - Manufacturability** ğŸŸ¡ **HIGH PRIORITY**
- **Effort:** 2 sessions
- **Blockers:** None (can start independently)
- **Deliverables:**
  - `Manufacturability.py` (300-400 lines)
  - Unit tests (minimum 8)
  - Integration tests (minimum 4)
  - Implementation report

**3. Phase 6 - Evidence_Package v3** ğŸŸ¡ **HIGH PRIORITY**
- **Effort:** 1-2 sessions
- **Blockers:** Phases 4-5 (for full integration)
- **Deliverables:**
  - Upgrade `wrap_trial_simulation()` to v3.0
  - JSON schema validation
  - Backward compatibility tests
  - v3.0 specification document

### **Integration & Polish (Phases 7-9):**

**4. Phase 7 - System Optimization** ğŸŸ¢ **MEDIUM PRIORITY**
- **Effort:** 1 session
- **Blockers:** None
- **Deliverables:**
  - Performance optimizations
  - Scaffold removal
  - Optimization report

**5. Phase 8 - Orchestrator v2** ğŸŸ¡ **HIGH PRIORITY**
- **Effort:** 1 session
- **Blockers:** Phases 4-6
- **Deliverables:**
  - `PX_Orchestrator_v2.py`
  - End-to-end tests
  - Implementation report

**6. Phase 9 - Final Validation** ğŸ”´ **CRITICAL**
- **Effort:** 1 session
- **Blockers:** Phases 4-8
- **Deliverables:**
  - Partner-ready certification
  - Full validation report
  - Release documentation

---

## ğŸ’¡ CONSTITUTIONAL COMPLIANCE STATUS

### **Current System (Phases 1-3):**
```
âœ… L51 (Zero Placeholders):       COMPLIANT
âœ… L34 (No Fabrication):          COMPLIANT
âœ… ALCOA+ (Data Integrity):       COMPLIANT
âœ… 9-Phase Protocol:              FOLLOWED
âœ… Zero Regressions:              MAINTAINED
âœ… Comprehensive Testing:         ACHIEVED
âœ… Full Documentation:            COMPLETE
```

### **Remaining Phases (4-9):**
```
âš ï¸  L51 (Zero Placeholders):       PENDING (Phases 4-5 needed)
âš ï¸  L34 (No Fabrication):          PENDING (Manufacturability SAS heuristic)
âœ… ALCOA+ (Data Integrity):       DESIGN COMPLIANT
âœ… 9-Phase Protocol:              BLUEPRINT ALIGNED
âš ï¸  Testing:                       PENDING (Phases 4-6 tests)
âš ï¸  Documentation:                 PENDING (Phase 4-6 reports)
```

---

## ğŸ“ FILES REQUIRING CREATION/MODIFICATION

### **Phase 4 (Dose Optimization v2):**
```
CREATE:
- PX_Engine/operations/DoseOptimizer_v2.py
- PX_Validation/tests/test_dose_optimizer_v2.py
- PX_Validation/tests/test_dose_optimizer_v2_integration.py
- PX_Audit/reports/DOSE_OPTIMIZATION_V2_IMPLEMENTATION_COMPLETE.md

MODIFY:
- README.md (add Phase 4 features)
- ROADMAP_v2.0.md (mark Phase 4 complete)
```

### **Phase 5 (Manufacturability):**
```
CREATE:
- PX_Engine/operations/Manufacturability.py
- PX_Validation/tests/test_manufacturability.py
- PX_Validation/tests/test_manufacturability_integration.py
- PX_Audit/reports/MANUFACTURABILITY_IMPLEMENTATION_COMPLETE.md

MODIFY:
- README.md (add Phase 5 features)
- ROADMAP_v2.0.md (mark Phase 5 complete)
```

### **Phase 6 (Evidence_Package v3):**
```
MODIFY:
- PX_System/foundation/Evidence_Package.py (upgrade to v3.0)

CREATE:
- PX_Validation/tests/test_evidence_package_v3.py
- PX_Audit/reports/EVIDENCE_PACKAGE_V3_SPECIFICATION.md
- schemas/TRIAL_DOSSIER_V3.json (JSON schema)

MODIFY:
- README.md (add Phase 6 features)
- ROADMAP_v2.0.md (mark Phase 6 complete)
```

### **Phases 7-9:**
```
CREATE:
- PX_Orchestrator_v2.py
- PX_Audit/reports/OPTIMIZATION_REPORT.md
- PX_Audit/reports/ORCHESTRATOR_V2_IMPLEMENTATION_COMPLETE.md
- PX_Audit/reports/PREDATOR_X_V2.0_CERTIFICATION.md
```

---

## âš ï¸ EXPLICIT LIMITATIONS

### **Current System Limitations (Phases 1-3):**

**None** - All features fully implemented and tested.

### **Pending Limitations (Phases 4-9):**

**Phase 4 (Dose Optimization):**
- âš ï¸  Mini-trial computational cost (10 patients Ã— N doses)
- âš ï¸  Coarse-to-fine may miss global optimum in non-convex spaces
- âš ï¸  Binary search assumes monotonicity (must validate)

**Phase 5 (Manufacturability):**
- âš ï¸  SAS is heuristic, not synthesis-validated (L34 risk)
- âš ï¸  Risk flags based on SMARTS patterns (not comprehensive)
- âš ï¸  Step count estimation is approximate
- âš ï¸  Formulation risk is proxy-based (no wet-lab data)

**Phase 6 (Evidence_Package v3):**
- âš ï¸  Dossier size may be large (1-5 MB) for complex trials
- âš ï¸  JSON schema validation adds computational overhead

**Phases 7-9:**
- âš ï¸  Performance benchmarks needed to quantify optimization gains
- âš ï¸  Orchestrator v2 requires all Phases 4-6 complete

---

## ğŸ“ RECOMMENDATIONS

### **Immediate Actions:**

1. **Start Phase 4 (Dose Optimization v2)**
   - Highest value-add for partners
   - No blockers
   - Clear specification in blueprint

2. **Start Phase 5 (Manufacturability) in Parallel**
   - Independent of Phase 4
   - Partner-critical capability
   - Can be developed concurrently

3. **Plan Phase 6 (Evidence v3) After 4-5**
   - Requires Phases 4-5 for full integration
   - Straightforward upgrade to existing code

4. **Reserve Phases 7-9 for Final Polish**
   - System optimization after features complete
   - Orchestrator integration requires all phases
   - Final validation after everything implemented

### **Success Criteria per Phase:**

**Each phase MUST achieve:**
- âœ… Code compiles and runs
- âœ… Unit tests â‰¥ 80% coverage
- âœ… Integration tests pass
- âœ… System tests pass (zero regressions)
- âœ… Documentation complete
- âœ… Constitutional compliance verified
- âœ… 9-Phase Protocol followed

---

## ğŸ“ AUDIT CONCLUSION

```
â•”â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•—
â•‘                                                              â•‘
â•‘              FORENSIC AUDIT COMPLETE                         â•‘
â•‘                                                              â•‘
â•‘  Status:        âš ï¸  33% COMPLETE (3/9 phases)               â•‘
â•‘  Quality:       âœ… EXCELLENT (Phases 1-3)                   â•‘
â•‘  Tests:         âœ… 97/97 PASSING (current system)           â•‘
â•‘  Regressions:   âœ… ZERO                                     â•‘
â•‘  Constitutional: âœ… COMPLIANT                                â•‘
â•‘                                                              â•‘
â•‘  Next Action:   ğŸš€ BEGIN PHASE 4 (DOSE OPTIMIZATION V2)     â•‘
â•‘  Estimated:     8-12 sessions to v2.0 completion           â•‘
â•‘                                                              â•‘
â•šâ•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
```

---

**Audit Completed:** January 26, 2026  
**Phases Complete:** 3/9 (33%)  
**Phases Pending:** 6/9 (67%)  
**System Status:** âœ… STABLE AND OPERATIONAL (Phases 1-3)  
**Recommendation:** âœ… **READY TO PROCEED WITH PHASE 4**

---

**ğŸ” FORENSIC AUDIT - GAPS IDENTIFIED AND DOCUMENTED ğŸ”**
